Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: Results of a randomised controlled trial

Walter Reinisch*, William J. Sandborn, Daniel W. Hommes, Geert D'Haens, Stephen Hanauer, Stefan Schreiber, Remo Panaccione, Richard N. Fedorak, Mary Beth Tighe, Bidan Huang, Wendy Kampman, Andreas Lazar, Roopal Thakkar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

746 Scopus citations

Fingerprint

Dive into the research topics of 'Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: Results of a randomised controlled trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry